Lefitolimod + Yervoy clinical trial estimate: Primary completion date of P1 trial (NCT02668770) for advanced solid malignancies in May 2021 (Cowen & Co) - Mar 30, 2021 - A subscription to REFINITIV is required to access document 91724681 | Page no: 110 | REPORT TITLE: "Investor's guide to immuno-oncology: Focus on novel targets-ahead of the curve" | AUTHOR: Boris Peaker, et al | DATE: 03/22/21
Trial primary completion date • Oncology • Solid Tumor
|
|
If you have access to Aftermarket Research from Refinitiv, please log in to your account using this link and enter report number or title to find the report. If you don’t have access but would like to purchase the report please contact [email protected].
|